Peifeng Liu
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Biosensors and Analytical Detection
Papers in
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 14
-
- Advanced biosensing and bioanalysis techniques 30
- RNA Interference and Gene Delivery 26
- DNA and Nucleic Acid Chemistry 6
- CRISPR and Genetic Engineering 6
Peifeng Liu
93 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Biomaterials 700
- Biomedical Engineering 885
- Molecular Biology 1.3k
- Molecular Medicine 77
- Pharmaceutical Science 82
Countries citing papers authored by Peifeng Liu
This map shows the geographic impact of Peifeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peifeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peifeng Liu more than expected).
Fields of papers citing papers by Peifeng Liu
This network shows the impact of papers produced by Peifeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peifeng Liu. The network helps show where Peifeng Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Peifeng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 30 | |
| 9 | 2023 | 62 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 43 | |
| 14 | 2020 | 19 | |
| 15 | 2018 | 12 | |
| 16 | 2017 | 95 | |
| 17 | 2016 | 54 | |
| 18 | 2015 | 22 | |
| 19 | 2013 | 47 | |
| 20 | 2012 | 16 |
About Peifeng Liu
Peifeng Liu is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Business and International Management and Cancer Research, having authored 97 papers that have together received 2.5k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (30 papers), RNA Interference and Gene Delivery (26 papers), Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (14 papers), DNA and Nucleic Acid Chemistry (6 papers), CRISPR and Genetic Engineering (6 papers), MicroRNA in disease regulation (5 papers) and High-Energy Particle Collisions Research (4 papers). The work is most often cited by research in Biomaterials (700 citations), Biomedical Engineering (885 citations), Molecular Biology (1.3k citations), Molecular Medicine (77 citations) and Pharmaceutical Science (82 citations). Peifeng Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Dan Luo, Xiaojing Chen, Ying Sun, Yue Hu, Dong Wang, Mingjie Zhu, Yourong Duan, Yourong Duan, Dayong Yang and Qianyun Tang. Their work appears in journals such as Advanced Materials, Biomaterials, Scientific Reports, Advanced Science and Nano Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.